glp-1 news today october 16 2025 Paving the way for expanded coverage | Insights & Events Top GLP-1 Agonists Balance Weight

Combination treatment with bortezomib and co-stimulation blockade preserved renal function, minimized antibody-mediated rejection (AMR), and extended graft kidney survival after kidney transplantation in a sensitized nonhuman monkey kidney transplant model[74]

More serious adverse effects include pancreatitis, gallbladder disease, and hypoglycemia when used with insulin or sulfonylureas

Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations

I just want you to know how desperate I became

Unique warnings for Farxiga Farxiga may increase the risk of diabetic ketoacidosis (DKA), a serious and potentially life-threatening condition, particularly in individuals with Type 1 diabetes or those with risk factors like low insulin, dehydration, or acute illness